Works matching IS 03407004 AND DT 2020 AND VI 69 AND IP 7
Results: 21
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1353, doi. 10.1007/s00262-020-02552-5
- By:
- Publication type:
- Article
Lymphocyte activation gene 3 (LAG3) protein expression on tumor-infiltrating lymphocytes in aggressive and TP53-mutated salivary gland carcinomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1363, doi. 10.1007/s00262-020-02551-6
- By:
- Publication type:
- Article
Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1327, doi. 10.1007/s00262-020-02550-7
- By:
- Publication type:
- Article
TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1315, doi. 10.1007/s00262-020-02549-0
- By:
- Publication type:
- Article
Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1307, doi. 10.1007/s00262-020-02548-1
- By:
- Publication type:
- Article
In vivo anti-MUC1+ tumor activity and sequences of high-affinity anti-MUC1-SEA antibodies.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1337, doi. 10.1007/s00262-020-02547-2
- By:
- Publication type:
- Article
Identification and validation of tumor environment phenotypes in lung adenocarcinoma by integrative genome-scale analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1293, doi. 10.1007/s00262-020-02546-3
- By:
- Publication type:
- Article
Tumor immune microenvironment in cancer patients with leukocytosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1265, doi. 10.1007/s00262-020-02545-4
- By:
- Publication type:
- Article
Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1253, doi. 10.1007/s00262-019-02465-y
- By:
- Publication type:
- Article
Regulatory T cells specifically suppress conventional CD8αβ T cells in intestinal tumors of APCMin/+ mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1279, doi. 10.1007/s00262-020-02540-9
- By:
- Publication type:
- Article
Predictive value of serum VEGF levels for elderly patients or for patients with poor performance status receiving anti-PD-1 antibody therapy for advanced non-small-cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1229, doi. 10.1007/s00262-020-02539-2
- By:
- Publication type:
- Article
Correction to: Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1177, doi. 10.1007/s00262-020-02536-5
- By:
- Publication type:
- Article
Adenosine-producing regulatory B cells in head and neck cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1205, doi. 10.1007/s00262-020-02535-6
- By:
- Publication type:
- Article
Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1191, doi. 10.1007/s00262-020-02534-7
- By:
- Publication type:
- Article
Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette–Guérin therapy for non-muscle invasive bladder cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1155, doi. 10.1007/s00262-020-02533-8
- By:
- Publication type:
- Article
Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1237, doi. 10.1007/s00262-020-02530-x
- By:
- Publication type:
- Article
Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1217, doi. 10.1007/s00262-020-02519-6
- By:
- Publication type:
- Article
Less is more: reducing the number of administered chimeric antigen receptor T cells in a mouse model using a mathematically guided approach.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1165, doi. 10.1007/s00262-020-02516-9
- By:
- Publication type:
- Article
Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1375, doi. 10.1007/s00262-020-02496-w
- By:
- Publication type:
- Article